Koning, Frits
Thomas, Ranjeny
Rossjohn, Jamie
Toes, Rene E.
Article History
First Online: 19 May 2015
Competing interests
: R.T. has filed patent applications (PCT/AU2007/001555: Compositions and methods for modulating immune responses, USA; PCT/AU2013/000303: Citrullinated aggrecan peptides for immunotherapy in rheumatoid arthritis, USA) related to technology for targeting dendritic cells to achieve antigen-specific tolerance, and is a director of Dendright, a spin-off company developing commercial vaccines that target dendritic cells to suppress autoimmune diseases. The other authors declare no competing interests.